Basic Suprax Information

• INN (International Nonproprietary Name): Cefixime
• Brand names available in Australia: Suprax
• ATC Code: J01DD08
• Forms & dosages: Tablets (400 mg), Oral suspension (100 mg/5 mL)
• Manufacturers in Australia: Lupin Pharmaceuticals
• Registration status in Australia: TGA approved
• OTC / Rx classification: Prescription-only (Rx)

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Careful monitoring is essential for specific groups while using Suprax due to the risk of complications. Elderly patients may experience a decline in renal function, which can affect medication clearance. Therefore, regular assessments are crucial in this demographic. Pregnant women should also approach this medication with caution, as it falls under Category B. While studies suggest a relative safety in pregnancy, it is pertinent to consult healthcare providers before use.

Individuals with chronic illnesses must consider potential interactions and side effects. Various conditions can alter how the body processes medications like Suprax, necessitating close observation by healthcare professionals. Health advice should always be tailored to individual circumstances for the safest outcomes.

Interaction with Activities (Driving, Workplace Safety Under Australian Law)

Taking Suprax may influence cognitive and motor functions, important factors for activities like driving. In Australia, legislation indicates that drivers must maintain a level of mental alertness and coordination while operating vehicles. If Suprax affects an individual's concentration or reaction times, it could potentially impair driving ability.

Health authorities advise patients to gauge their own response to the medication before engaging in tasks that require focused attention, such as driving or handling machinery. If there is any doubt, it’s recommended to err on the side of caution.

Q&A — “Can I drive after taking it in Australia?”

Driving after taking Suprax generally depends on individual tolerance and the side effects experienced. Some patients might not feel any impairment, while others could experience dizziness or drowsiness. It’s advisable to wait until you fully understand how the medication affects you before getting behind the wheel. Your safety and that of others is paramount, so always prioritise caution in such situations.

Usage Basics

INN, brand names available in Australia

Cefixime, the International Nonproprietary Name (INN), is known for its effectiveness in treating various bacterial infections. In Australia, this antibiotic is available under several brand names.

Notably, Suprax is the primary brand name associated with this drug. However, pharmacists may also carry other formulations of cefixime, depending on the supplier and stock availability. It’s important for patients to consult with their healthcare provider or pharmacist about the specific options available. Other global brands include Cefspan and Cefix, which may also be familiar to consumers from international markets.

Local packaging is generally tailored for various forms like tablets and oral suspensions. The standard dosage for Suprax includes 400 mg tablets and oral suspensions specially formulated for pediatric patients, available in strengths of 100 mg/5 mL.

Legal classification (TGA-approved, PBS-listed)

Suprax holds a significant position in Australia's regulatory landscape as a Therapeutic Goods Administration (TGA)-approved antibiotic. This status signifies that Suprax has met the necessary safety, efficacy, and quality standards set by the TGA.

Furthermore, Suprax is listed on the Pharmaceutical Benefits Scheme (PBS), making it accessible and affordable for Australians requiring this medication. The PBS listing means that eligible patients can receive Suprax at a reduced cost, whereas others may purchase it without a prescription, underscoring its importance in treating bacterial infections effectively.

The combined TGA approval and PBS listing demonstrate a commitment to robust healthcare solutions, ensuring patients can access essential medications while managing treatment costs effectively.

Dosing Guide

Standard regimens (PBS reference dosing)

Understanding the proper dosing of Suprax (Cefixime) is crucial for effective treatment. The PBS recommends these general dosages depending on the condition:

• Uncomplicated UTI: 400 mg once daily or 200 mg every 12 hours.
• Otitis media: 400 mg once daily.
• Pharyngitis/Tonsillitis: 400 mg daily for 5–10 days.
• Gonorrhea: 400 mg as a single dose.
• Acute bronchitis: 400 mg once daily.

For paediatric patients aged 6 months to 12 years, the dosage is often calculated based on body weight, typically at 8 mg/kg once daily or 4 mg/kg every 12 hours.

Adjustments for comorbidities

Patients with comorbidities may require dose adjustments to ensure safety and efficacy. Here are key considerations:

• Renal impairment: If creatinine clearance is less than 60 mL/min, the dose should be halved.
• Elderly: No specific dosage adjustments are usually necessary, but monitoring is essential due to potential renal function decline.
• Hepatic impairment: Currently, no adjustments are recommended, but caution is warranted in severe cases.

It’s vital for healthcare providers to assess individual patient circumstances before determining the appropriate regimen.

Q&A — “What if I miss a dose?”

Missing a dose can be concerning, but here’s what to do:

• If a dose is remembered soon enough, it can be taken as quickly as possible.
• If it's almost time for the next dose, skip the missed dose and resume the regular schedule.
• Never double the dose to make up for a missed one.

Staying consistent with the dosing schedule helps maintain effective drug levels in the body, ensuring the best outcomes from Suprax treatment.

Delivery Information